Cardinal Health expands pharmaceutical distribution contracts with CVS Health

By Sean Whooley | August 11, 2021

Cardinal Health (NYSE:CAH) announced that it extended agreements with CVS Health over pharmaceutical distribution.

The agreements for the distribution of pharmaceuticals to retail pharmacies and distribution centers run through June 30, 2027, according to a news release.

“We value our long-standing partnership with CVS Health, and we are honored to continue our important work together to bring our best-in-class abilities together for their customers,” Cardinal Health CEO Mike Kaufmann said in the release.

The agreement has no bearings on Cardinal Health’s financial projections, with the company’s 2022 adjusted EPS guidance range remaining between $5.60 and $5.90.

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.